Clinical trials
Phase 1 Lung Neoplasms trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 4 |
| 2022 | 4 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 5 |
| Terminated | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Amgen | 2 |
| Blueprint Medicines Corporation | 2 |
| Eli Lilly and Company | 1 |
| Golden Biotechnology Corporation | 1 |
| IDEAYA Biosciences | 1 |
| MedImmune LLC | 1 |
| OBI Pharma, Inc | 1 |
| Revolution Medicines, Inc. | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 17 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Colorectal Neoplasms | 6 |
| Neoplasms | 6 |
| Breast Neoplasms | 4 |
| Colonic Neoplasms | 4 |
| Rectal Neoplasms | 4 |
| Adenocarcinoma | 3 |
| Bronchial Neoplasms | 3 |
| Esophageal Neoplasms | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.